(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MOASIS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: Estados Unidos

Snapshot rápido

MOASIS

ST13

US500000079348305

Classe

3, 5

Pedido

79348305

Registro

7256718

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

32

Atualização mais recente

05/07/2025

Tipo de marca

Verbal

Classes Nice

3, 5

Data de depósito

27/07/2022

Data de registro

02/01/2024

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

02/01/2024

Última transação

05/07/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

03

Localização do titular

KR

Examinador

BULLOFF, TOBY

Unidade examinadora

N10

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

SCAI THERAPEUTICS CO., LTD.

Representantes

Kwang Yup Chae Hauptman Ham, LLP

Classificação técnica

Classes Nice

Classe 3Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 3

Cosmetic preparations for skin renewal; Compacts containing make-up; Cosmetic preparations for body care; Beauty care cosmetics; Phytocosmetic preparations; Cosmetics; Cosmetics in the form of lotions; Non-medicated cosmetics; Serums for cosmetic purposes; Cosmetics for use on the skin; Nourishing cosmetic cream; Cosmetics in the form of milkslotions and emulsions; Cosmetic preparations for hair care; Sunscreen lotion; Sunscreen oil; Moisturising cosmetic lotions; Cosmetics for animals

Classe 5

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Medicines for human purposespharmaceutical preparations for the treatment and prevention of ocular disorders and diseasepain relief medication; Pharmaceutical preparations for the prevention of ocular diseases; Medicinal preparations for the mouth to be applied in the form of dropscapsulestablets and compressed tablets; Pharmaceutical preparations for use in dermatology; Pharmaceutical agents for epidermis; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the prevention of diseases caused by bacteria; Pharmaceutical preparations for the treatment of diseases caused by bacteria; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations for the treatment and prevention of ocular disorders and diseasethe relief of pain; Pharmaceutical drugs for the treatment and prevention of ocular disorders and diseasethe relief of pain; Ophthalmic preparations; Pharmaceutical preparations for ocular use; Eye drops; Pharmaceutical creamstopical analgesic creamsantibiotic creamsmedicated topical creams to promote fat burning; Creams for dermatological use; Oral vaccine preparations; Vaccines

Publicações

Histórico de despachos e eventos da marca no USPTO.

32 publicações encontradas

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

04/07/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

29/04/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/04/2024

FIMP

FINAL DISPOSITION PROCESSED

08/04/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/04/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/01/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

02/01/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

17/10/2023

PUBO

PUBLISHED FOR OPPOSITION

17/10/2023

GPNX

NOTIFICATION PROCESSED BY IB

16/10/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

27/09/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

27/09/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

27/09/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/09/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/09/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/09/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/09/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

21/08/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

21/08/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

21/08/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

21/08/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

21/08/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

21/08/2023

RFNP

REFUSAL PROCESSED BY IB

10/07/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

20/06/2023

RFRR

REFUSAL PROCESSED BY MPU

19/06/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

16/05/2023

CNRT

NON-FINAL ACTION WRITTEN

15/05/2023

DOCK

ASSIGNED TO EXAMINER

15/05/2023

MAFR

APPLICATION FILING RECEIPT MAILED

30/08/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

26/08/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

25/08/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MOASIS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.